TELFAST fexofenadine hydrochloride 60mg tablet

Land: Australien

Sprache: Englisch

Quelle: Department of Health (Therapeutic Goods Administration)

Wirkstoff:

fexofenadine hydrochloride, Quantity: 60 mg

Verfügbar ab:

Sanofi-Aventis Healthcare Pty Ltd T/A Sanofi Consumer Healthcare

INN (Internationale Bezeichnung):

Fexofenadine hydrochloride

Darreichungsform:

Tablet, film coated

Zusammensetzung:

Excipient Ingredients: microcrystalline cellulose; magnesium stearate; colloidal anhydrous silica; croscarmellose sodium; titanium dioxide; povidone; pregelatinised maize starch; hypromellose; macrogol 400; iron oxide red; iron oxide yellow

Verabreichungsweg:

Oral

Einheiten im Paket:

20 Not to be supplied before the effective date of the amendment to the Poisons Schedule, 10

Verschreibungstyp:

Not Scheduled after consideration by Committee

Anwendungsgebiete:

Relief of symptoms associated with seasonal allergic rhinitis in adults and children aged 12 years and older.

Produktbesonderheiten:

Visual Identification: Peach, oval, double convex, tablets, debossed with ?06? on one side and a scripted ?e? on the other.; Container Type: Blister Pack; Container Material: PVC/PE/PVDC/Al; Container Life Time: 36 Months; Container Temperature: Store below 30 degrees Celsius

Berechtigungsstatus:

Licence status A

Berechtigungsdatum:

2009-10-13